This post was originally published on this site
Last Updated:
First Published:
Humana Inc.’s stock closed down another 1.9% on Thursday to bring its week-to-date losses to 24.3%, after BofA Securities downgraded it to underperform — or sell — on concerns about a delay in margin recovery.
The move comes a day after the health insurer
HUM said one its key Medicare Advantage plans looks set to have its government rating cut, which would reduce reimbursement rates. The stock sold off Wednesday on the news and led S&P 500 SPX decliners.
